Argitalpenak (16) Maruan Hijazi Vega argitalpenak

2023

  1. Community detection in empirical kinase networks identifies new potential members of signalling pathways

    PLoS Computational Biology, Vol. 19, Núm. 6

  2. Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics

    Biomedicine and Pharmacotherapy, Vol. 158

2022

  1. Implementation of Clinical Phosphoproteomics and Proteomics for Personalized Medicine

    Methods in Molecular Biology (Humana Press Inc.), pp. 87-106

  2. Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment

    Science Signaling, Vol. 15, Núm. 730

  3. eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors

    Molecular and Cellular Proteomics, Vol. 21, Núm. 7

2021

  1. Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells

    Cell, Vol. 181, Núm. 6, pp. 1346-1363.e21

  2. PARP-1 activation after oxidative insult promotes energy stress-dependent phosphorylation of YAP1 and reduces cell viability

    The Biochemical journal, Vol. 477, Núm. 23, pp. 4491-4513

  3. Prediction of Signed Protein Kinase Regulatory Circuits

    Cell Systems, Vol. 10, Núm. 5, pp. 384-396.e9

  4. Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring

    Nature Biotechnology, Vol. 38, Núm. 4, pp. 493-502

2019

  1. Abstract C088: Chemical phosphoproteomics systematically identifies circuitries of kinase networks in cancer cells and predicts their response to kinase inhibitors

    Molecular Cancer Therapeutics, Vol. 18, Núm. 12_Supplement, pp. C088-C088

2017

  1. Impact of phosphoproteomics in the translation of kinase-targeted therapies

    Proteomics, Vol. 17, Núm. 6

  2. Restrained Phosphatidylcholine Synthesis in a Cellular Model of Down’s Syndrome is Associated with the Overexpression of Dyrk1A

    Molecular Neurobiology, Vol. 54, Núm. 2, pp. 1092-1100

2016

  1. Oleic Acid and Cholinergic dysfunction in Down Syndrome Models of the Central Nervous System

    Journal of Neurology and Neuromedicine, Vol. 1, Núm. 3, pp. 1-5

2013

  1. Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome

    Experimental Neurology, Vol. 239, Núm. 1, pp. 229-234

2012

  1. Neuronal differentiation promoted by oleic acid is impaired in TgDyrk1A primary neuronal culture

    FEBS Journal